AVEXIS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 80 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-05-15: Reporting owner WELCH DANIEL G; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-05-15: Reporting owner WELCH DANIEL G; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-05-15: Reporting owner WELCH DANIEL G; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2018-05-15: Reporting owner Verwiel Frank; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-05-15 | WELCH DANIEL G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,552 0 owned after | $20.00 exercise price | 2018-05-15 | |
| 2018-05-15 | WELCH DANIEL G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,454 0 owned after | $69.25 exercise price | 2018-05-15 | |
| 2018-05-15 | WELCH DANIEL G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,905 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Verwiel Frank Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −26,496 0 owned after | $20.00 exercise price | 2018-05-15 | |
| 2018-05-15 | Verwiel Frank Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,454 0 owned after | $69.25 exercise price | 2018-05-15 | |
| 2018-05-15 | Verwiel Frank Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,905 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Smith Lori J. Officer (SVP-Chief Human Resource Off.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,400 0 owned after | $68.40 exercise price | 2018-05-15 | |
| 2018-05-15 | Smith Lori J. Officer (SVP-Chief Human Resource Off.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,925 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Smith Lori J. Officer (SVP-Chief Human Resource Off.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,233 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Siffert Joao MD Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,755 0 owned after | $69.25 exercise price | 2018-05-15 | |
| 2018-05-15 | Siffert Joao MD Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,905 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Session R.A. II Officer (Sr. VP, Corp Strategy) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,950 0 owned after | $79.75 exercise price | 2018-05-15 | |
| 2018-05-15 | Session R.A. II Officer (Sr. VP, Corp Strategy) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,282 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Session R.A. II Officer (Sr. VP, Corp Strategy) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,572 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Nolan Sean P. Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −728,300 0 owned after | $15.94 exercise price | 2018-05-15 | |
| 2018-05-15 | Nolan Sean P. Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −110,000 0 owned after | $42.61 exercise price | 2018-05-15 | |
| 2018-05-15 | Nolan Sean P. Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −96,000 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Nolan Sean P. Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −178,494 0 owned after | $18.47 exercise price | 2018-05-15 | |
| 2018-05-15 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37,750 0 owned after | $42.61 exercise price | 2018-05-15 | |
| 2018-05-15 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,200 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Modi Rick Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −61,000 0 owned after | $57.88 exercise price | 2018-05-15 | |
| 2018-05-15 | Modi Rick Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,940 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Modi Rick Officer (Chief Business Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Manning Paul B | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −26,496 0 owned after | $20.00 exercise price | 2018-05-15 | |
| 2018-05-15 | Manning Paul B | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,454 0 owned after | $69.25 exercise price | 2018-05-15 | |
| 2018-05-15 | Manning Paul B | 4 | Stock Option (Right to Buy) Derivative · Direct · (m) | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,905 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −141,800 0 owned after | $18.17 exercise price | 2018-05-15 | |
| 2018-05-15 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37,750 0 owned after | $42.61 exercise price | 2018-05-15 | |
| 2018-05-15 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,827 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Koh Bong Y Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −26,496 0 owned after | $20.00 exercise price | 2018-05-15 | |
| 2018-05-15 | Koh Bong Y Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,454 0 owned after | $69.25 exercise price | 2018-05-15 | |
| 2018-05-15 | Koh Bong Y Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,905 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −141,800 0 owned after | $18.17 exercise price | 2018-05-15 | |
| 2018-05-15 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −37,750 0 owned after | $42.61 exercise price | 2018-05-15 | |
| 2018-05-15 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,827 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Performance Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,778 8,778 owned after | $0.00 | 2018-05-15 | |
| 2018-05-15 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Performance Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,778 0 owned after | $0.00 | 2018-05-15 | |
| 2018-05-15 | Kearney Terrence C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −26,496 0 owned after | $20.00 exercise price | 2018-05-15 | |
| 2018-05-15 | Kearney Terrence C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,454 0 owned after | $69.25 exercise price | 2018-05-15 | |
| 2018-05-15 | Kearney Terrence C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,905 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Kaspar Brian K. Director, Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −32,501 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Kaspar Brian K. Director, Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Johannesen Michael Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −44,700 0 owned after | $36.02 exercise price | 2018-05-15 | |
| 2018-05-15 | Johannesen Michael Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,500 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Johannesen Michael Officer (General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-05-15 | Donenberg Phillip B. Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,000 0 owned after | $37.58 exercise price | 2018-05-15 | |
| 2018-05-15 | Donenberg Phillip B. Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,594 0 owned after | $77.24 exercise price | 2018-05-15 | |
| 2018-05-15 | Donenberg Phillip B. Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,406 0 owned after | $88.08 exercise price | 2018-05-15 | |
| 2018-05-15 | Donenberg Phillip B. Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,000 0 owned after | $100.52 exercise price | 2018-05-15 | |
| 2018-05-15 | Donenberg Phillip B. Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $133.80 exercise price | 2018-05-15 | |
| 2018-04-02 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 141,800 owned after | $18.17 exercise price | 2018-04-04 | |
| 2018-04-02 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 141,800 owned after | $18.17 exercise price | 2018-04-04 | |
| 2018-03-13 | Koh Bong Y Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,905 2,905 owned after | $133.80 exercise price | 2018-03-30 | |
| 2018-03-13 | Siffert Joao MD Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,905 2,905 owned after | $133.80 exercise price | 2018-03-30 | |
| 2018-03-13 | Kearney Terrence C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,905 2,905 owned after | $133.80 exercise price | 2018-03-30 | |
| 2018-03-13 | Manning Paul B | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,905 2,905 owned after | $133.80 exercise price | 2018-03-30 | |
| 2018-03-13 | Verwiel Frank Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,905 2,905 owned after | $133.80 exercise price | 2018-03-30 | |
| 2018-03-13 | WELCH DANIEL G Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,905 2,905 owned after | $133.80 exercise price | 2018-03-30 | |
| 2018-03-13 | Smith Lori J. Officer (SVP-Chief Human Resource Off.) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,233 9,233 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Session R.A. II Officer (Sr. VP, Corp Strategy) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,572 6,572 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Modi Rick Officer (Chief Business Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Kaspar Brian K. Director, Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Johannesen Michael Officer (General Counsel) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Donenberg Phillip B. Officer (Chief Financial Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-13 | Nolan Sean P. Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +44,000 44,000 owned after | $133.80 exercise price | 2018-03-27 | |
| 2018-03-07 | Nolan Sean P. Director, Officer (President & CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 728,300 owned after | $15.94 exercise price | 2018-03-09 | |
| 2018-03-01 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 143,800 owned after | $18.17 exercise price | 2018-03-05 | |
| 2018-02-01 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,780 178,494 owned after | $18.47 exercise price | 2018-03-05 | |
| 2018-02-01 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,780 180,274 owned after | $18.47 exercise price | 2018-02-05 | |
| 2018-02-01 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 145,800 owned after | $18.17 exercise price | 2018-02-05 | |
| 2018-01-16 | LITALIEN JAMES J Officer (SrVP/Chief Reg&Quality Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 146,800 owned after | $18.17 exercise price | 2018-01-18 | |
| 2018-01-02 | Knudten Andrew F. Officer (SrVP/Manufacture&Supply Chain) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,000 147,800 owned after | $18.17 exercise price | 2018-01-04 | |
| 2018-01-02 | Nagendran Sukumar Officer (Sr. VP & Chief Medical Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,780 182,054 owned after | $18.47 exercise price | 2018-01-04 |